Ewa Sujka Higuera, explains the importance of phytobiotics nowadays, and its current situation and challenges, during IPPE 2019
*Certain information associated with products, their composition and claims may be different depending on the geographical region and may not be applicable in all countries. Liptosa reserves the right to adapt to the requirements and legislation in each case.
The information and technical recommendations provided herein are based on Liptosa's current knowledge and experience.
Liptosa reserves the right to update the information and arguments contained in this platform, as well as to make any changes to this information or recommendation at any time, without prior or subsequent notice.
This audiovisual material contains technical and validated terminology inherent to the time of content generation, editing and publication. Nevertheless, LIPTOSA is committed to scientific and technical progress and continuously updates its content.
Dear Dr. Krishna, Thank you for your comments. As it is well known, and for sure within your company experience as well, phytobiotic mode of action is complex and multifactorial: combines direct and indirect activity over pathogen. When you refer to synthetic solutions I suppose you mean conventional drugs - that's correct?
Great video!
However id like to know more about the mechanism with which the Phytobiotics from Liptosa are working.
The usual notion is that plant based chemicals may not be as efficacious as their synthetic counterparts, is Liptosa looking alleviate this common notion?
What makes Liptosa's phytobiotics different from the other phytogenic companies?